Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
Background/Aims: Gastroesophageal reflux disease (GERD) is a chronic and recurrent condition requiring constant dietary management and medication. This study evaluated the efficacy and safety of HIP1601, a dual delayed-release formulation of esomeprazole, in patients with GERD in a clinical setting....
Saved in:
Main Authors: | Hyun Lim, Moon-hwa Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2025-01-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.kjg.or.kr/journal/view.html?uid=6079&vmd=Full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01) -
Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-05-01) -
Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01) -
New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)